Correlation Between TC BioPharm and Heart Test
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and Heart Test at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and Heart Test into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm plc and Heart Test Laboratories, you can compare the effects of market volatilities on TC BioPharm and Heart Test and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of Heart Test. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and Heart Test.
Diversification Opportunities for TC BioPharm and Heart Test
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between TCBPW and Heart is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and Heart Test Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Heart Test Laboratories and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with Heart Test. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Heart Test Laboratories has no effect on the direction of TC BioPharm i.e., TC BioPharm and Heart Test go up and down completely randomly.
Pair Corralation between TC BioPharm and Heart Test
Assuming the 90 days horizon TC BioPharm plc is expected to generate 4.27 times more return on investment than Heart Test. However, TC BioPharm is 4.27 times more volatile than Heart Test Laboratories. It trades about 0.2 of its potential returns per unit of risk. Heart Test Laboratories is currently generating about -0.58 per unit of risk. If you would invest 1.14 in TC BioPharm plc on September 1, 2024 and sell it today you would earn a total of 0.73 from holding TC BioPharm plc or generate 64.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 14.29% |
| Values | Daily Returns |
TC BioPharm plc vs. Heart Test Laboratories
Performance |
| Timeline |
| TC BioPharm plc |
| Heart Test Laboratories |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
TC BioPharm and Heart Test Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with TC BioPharm and Heart Test
The main advantage of trading using opposite TC BioPharm and Heart Test positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, Heart Test can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Heart Test will offset losses from the drop in Heart Test's long position.| TC BioPharm vs. Tff Pharmaceuticals | TC BioPharm vs. Eliem Therapeutics | TC BioPharm vs. Inhibrx | TC BioPharm vs. Enliven Therapeutics |
| Heart Test vs. Heart Test Laboratories | Heart Test vs. Inspira Technologies Oxy | Heart Test vs. TC BioPharm plc | Heart Test vs. bioAffinity Technologies Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |